Antiretroviral Therapy (ART)
Antiretroviral Therapy (ART) is a pharmaceutical drug with 8 clinical trials. Historical success rate of 60.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
42.9%
3 of 7 finished
57.1%
4 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Baricitinib Curative Repression of HIV-1
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients
Understanding the Increased Risk of Cardiovascular Disease in People With HIV
Clinical Trials (8)
Baricitinib Curative Repression of HIV-1
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients
Understanding the Increased Risk of Cardiovascular Disease in People With HIV
Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy
Aspirin and Antiretroviral Therapy in HIV Infected Patients
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8